Fukushima Hiroshi, Inoue Masaharu, Kijima Toshiki, Yoshida Soichiro, Yokoyama Minato, Ishioka Junichiro, Matsuoka Yoh, Saito Kazutaka, Fujii Yasuhisa
Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan; Department of Urology, National Cancer Center East Hospital, Kashiwa, Japan.
Clin Genitourin Cancer. 2020 Oct;18(5):e619-e628. doi: 10.1016/j.clgc.2020.02.004. Epub 2020 Feb 10.
We aimed to evaluate the incidence and risk factors for nephrectomy-related hypertension (NR-HT) in patients with renal tumors who underwent partial nephrectomy (PN) or radical nephrectomy (RN).
A retrospective cross-sectional follow-up survey of postoperative home blood pressure (BP) and defined daily dose (DDD) of antihypertensive medications was conducted in patients with renal tumors who underwent PN (210 patients) or RN (120 patients), and they were compared. We evaluated the incidence and risk factors for NR-HT, defined as the addition of antihypertensive medications in doses of 1 DDD or more after surgery, or postoperative BP of 140/90 mmHg with an increase of 20 mmHg from preoperative BP with no reduction in dose of antihypertensive medications.
Both systolic (mean, 124 vs. 129 mmHg; P < .001) and diastolic BP (mean, 74 vs. 79 mmHg; P < .001) significantly increased after PN compared with RN. Systolic (P < .001) and diastolic (P = .003) BP increased significantly more after PN than after RN, and NR-HT was more frequent after PN than after RN (16% vs. 5%; P = .002). PN (odds ratio [OR], 2.93; P = .022) and higher postoperative peak C-reactive protein (OR, 2.34; P = .017) were independently associated with NR-HT. When limited to only the patients who underwent PN, acute kidney injury (OR, 2.65; P = .036) and higher postoperative peak C-reactive protein (OR, 2.54; P = .016) were independent risk factors for NR-HT.
PN may cause postoperative progression of hypertension possibly through renal parenchymal damage.
我们旨在评估接受部分肾切除术(PN)或根治性肾切除术(RN)的肾肿瘤患者中与肾切除相关的高血压(NR-HT)的发生率及危险因素。
对接受PN(210例患者)或RN(120例患者)的肾肿瘤患者进行了术后家庭血压(BP)及抗高血压药物限定日剂量(DDD)的回顾性横断面随访调查,并进行比较。我们评估了NR-HT的发生率及危险因素,NR-HT定义为术后添加剂量为1个DDD或更高剂量的抗高血压药物,或术后血压为140/90 mmHg且较术前血压升高20 mmHg,同时抗高血压药物剂量未减少。
与RN相比,PN后收缩压(平均值,124对129 mmHg;P <.001)和舒张压(平均值,74对79 mmHg;P <.001)均显著升高。PN后收缩压(P <.001)和舒张压(P =.003)升高幅度显著大于RN后,且PN后NR-HT比RN后更常见(16%对5%;P =.002)。PN(比值比[OR],2.93;P =.022)及术后C反应蛋白峰值较高(OR,2.34;P =.017)与NR-HT独立相关。当仅局限于接受PN的患者时,急性肾损伤(OR,2.65;P =.036)及术后C反应蛋白峰值较高(OR,2.54;P =.016)是NR-HT的独立危险因素。
PN可能通过肾实质损伤导致术后高血压进展。